Clinical trial
Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal…
NCT00345202 · Regional Hospital Holstebro, Other · Completed
Key facts
| NCT number | NCT00345202 |
|---|---|
| Title | Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects |
| Official title | Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects. |
| Lead sponsor | Regional Hospital Holstebro, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | HMG-CoA reductase inhibition (atorvastatin) |
| Enrollment | 20 |
| Start date | Sep 1, 2004 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Jun 27, 2006 |
| Last update posted | May 15, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: